Who Owns PharmaCyte Biotech Stock?
NASDAQ: PMCBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 7.11%
- Held by insiders
- 5.74%
- Institutional holders
- 34
- Institutions 7.1%
- Insiders 5.7%
- Public and other 87.2%
Who owns PharmaCyte Biotech stock?
Institutional investors own about 7.1% of PharmaCyte Biotech's shares, spread across 34 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 5.74% of PMCB.
The largest institutional holders are Citadel Advisors Llc (0.01%), Geode Capital Management, LLC (0.01%) and Vanguard Capital Management LLC (0.00%). Together, the top 10 institutions control 0.0% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their PMCB positions and 6 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PMCB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Citadel Advisors Llc | 283.38K | 0.01% | -21.2% |
| Geode Capital Management, LLC | 124.25K | 0.01% | -36.5% |
| Vanguard Capital Management LLC | 56.78K | 0.00% | +10.3% |
| Susquehanna International Group, LLP | 44.85K | 0.00% | +100.0% |
| Renaissance Technologies, LLC | 37.99K | 0.00% | -32.8% |
| Xtx Topco Ltd | 34.18K | 0.00% | -34.7% |
| Northern Trust Corporation | 32.62K | 0.00% | -8.4% |
| Jane Street Group, LLC | 30.06K | 0.00% | +160.8% |
| Schonfeld Strategic Advisors Llc | 26.93K | 0.00% | -0.3% |
| Vanguard Fiduciary Trust Co | 23.45K | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PMCB
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 58.55K | 0.00% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 56.78K | 0.00% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 17.45K | 0.00% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 15.26K | 0.00% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 12.90K | 0.00% |
Frequently asked questions
Who is the largest shareholder of PharmaCyte Biotech?
Citadel Advisors Llc is the largest institutional shareholder of PMCB, owning 0.01% of shares outstanding (283.38K shares) as of its latest 13F filing.
What percentage of PharmaCyte Biotech is owned by institutions?
Institutions own about 7.1% of PMCB shares and 7.5% of the public float.
How much of PharmaCyte Biotech do insiders own?
Insiders, such as officers and directors, own about 5.74% of PMCB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.